ANMI inks deal for SPECT radiopharmaceutical

Advanced Nuclear Medicine Ingredients (ANMI) has signed an agreement to license...Read more on AuntMinnie.comRelated Reading: Ga-68 PSMA-11 PET/MRI benefits prostate cancer patients New SPECT tracer targets NSCLC receptor Ga-68 PSMA-11 PET/MRI advances prostate cancer detection Study warns of PSMA-PET imaging discrepancies Gallium-labeled PET tracer could advance cancer detection
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news